開能健康(300272.SZ)一季度預盈2000萬-3000萬元
格隆匯 4 月 13日丨開能健康(300272.SZ)公佈,預計2021年第一季度歸屬於上市公司股東的淨利潤2000萬元-3000萬元,上年同期盈利86.82萬元;扣除非經常性損益後的淨利潤2000萬元-2500萬元。
報吿期內,受益於國內外疫情的大幅緩解,公司核心主業的淨水市場已恢復正常,景氣指數逐漸復甦。在此期間,公司各業務部門搶抓國內、國外下游客户消費復甦的各種商機,在持續賦能助力國內終端和國內ODM業務的同時,藉助新品上市和國內供應鏈實力提升的大好機遇,加大了國外市場的開拓力度,共同推動公司核心業務的銷售收入較上年同期大幅增長,營收增幅超過60%,與未爆發疫情的前年同期營收相比也大幅增長近70%;
報吿期內,公司持續優化管理,提升管理效率,期間費用管控較好,管理費用佔營收比重下降約6個百分點,從而推動公司扣除非經常性損益前後的歸屬於上市公司股東的淨利潤與上年同期相比大幅上升。
報吿期內,公司預計非經常性損益對淨利潤的影響金額約為270萬元。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.